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Androgens regulate scarless repair of the endometrial
“wound” in a mouse model of menstruation
Fiona L. Cousins,* Phoebe M. Kirkwood,* Alison A. Murray,† Frances Collins,* Douglas A. Gibson,*
and Philippa T. K. Saunders*,1
*Medical Research Council (MRC) Centre for Inflammation Research and †MRC Centre for Reproductive Health, The University of Edinburgh,
Queen’s Medical Research Institute, Edinburgh, United Kingdom
ABSTRACT: The human endometriumundergoes regular cycles of synchronous tissue shedding (wounding) and repair
that occurduringmenstruationbeforeestrogen-dependent regeneration.Endometrial repair isnormallyboth rapidand
scarless. Androgens regulate cutaneous wound healing, but their role in endometrial repair is unknown. We used a
murine model of simulated menses; mice were treated with a single dose of the nonaromatizable androgen dihy-
drotestosterone (DHT; 200 mg/mouse) to coincide with initiation of tissue breakdown. DHT altered the duration of
vaginal bleeding and delayed restoration of the luminal epithelium. Analysis of uterine mRNAs 24 h after adminis-
tration of DHT identified significant changes in metalloproteinases (Mmp3 and -9; P < 0.01), a snail family member
(Snai3; P < 0.001), and osteopontin (Spp1; P < 0.001). Chromatin immunoprecipitation analysis identified putative
androgenreceptor (AR)bindingsites in theproximalpromotersofMmp9,Snai3, andSpp1.Strikingspatialandtemporal
changes in immunoexpressionofmatrixmetalloproteinase (MMP)3/9andcaspase3weredetectedafterDHTtreatment.
These data represent a paradigm shift in our understanding of the role of androgens in endometrial repair and suggest
that androgensmayhavedirect impacts onendometrial tissue integrity. These studiesprovide evidence that theAR is a
potential target for drug therapy to treat conditions associated with aberrant endometrial repair processes.—Cousins,
F. L., Kirkwood, P.M.,Murray,A.A., Collins, F.,Gibson,D.A., Saunders, P. T.K.Androgens regulate scarless repair of
the endometrial “wound” in a mouse model of menstruation. FASEB J. 30, 000–000 (2016). www.fasebj.org
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In women, the most important tissues for biosynthesis of
androgens are the ovaries, adrenals, and fat. In adult
women, 50% of the testosterone measured in blood is se-
creted by the ovaries and adrenals, with a small midcycle
peak (1). The other 50% is derived from conversion of
adrenal and ovarian precursors, such as androstenedione,
dehydroepiandrosterone, and dehydroepiandrosterone
sulfate. Testosterone can be further metabolized to both
estradiol and the potent nonaromatizable androgen
dihydrotestosterone (DHT) in tissues that express aro-
matase and 5-a reductase enzymes, respectively (1–3).
During themenstrual cycle, endometrial breakdown at
the timeofmenses is the culminationof a tightly controlled
cascade of biomolecular changes initiated byprogesterone
(P4) withdrawal (demise of the corpus luteum), which
results in shedding of the upper functional layer of
the endometrium. Detailed morphologic evaluation in
women has revealed that breakdown and restoration of
tissue homeostasis at the time ofmenstruation in normal
women occurs rapidly, with epithelialization of the ex-
posed basal stroma completed within 4 d of the first
evidence of bleeding (4, 5). Piecemeal degradation and
bleeding that give the surface of the endometrium the
appearance of a wound has been documented with a
hysteroscope introduced via the vagina and cervix (4). At
the time of tissue breakdown, there is concurrent neo-
angiogenesis, stabilization of residual basal blood ves-
sels, and rapid reepithelialization (4). The repair of the
endometrium inwomen is coincidentwith the time in the
cycle when estrogens and P4 are at their lowest (6).
Inbred mice do not spontaneously menstruate, but we
(7) and others (8, 9) have used hormonal manipulation of
ovariectomized mice combined with manual stimulation
of the endometrium to induce decidualization to replicate
the key features of the process in women, including syn-
chronoussheddingandrepairandrapidreepithelialization.
ABBREVIATIONS: AR, androgen receptor; ARE, androgen response ele-
ment; ChIP, chromatin immunoprecipitation; DHT, dihydrotestosterone;
MMP, matrix metalloproteinase; P4, progesterone
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In addition, results in xenografts of human endometrial
tissue maintained in nude mice (10) have complemented
the studies inmice (9), showing that restoration of an intact
endometrial epithelium is independent of the action of
estrogens. These findingsdistinguish themenstrual phase
from the subsequent proliferative phase, during which
rising concentrations of follicle-derived estrogens play a
crucial role in endometrial growth and regeneration, as
well as in promotingP4 receptor expression [seeHewitt et
al. (11)].
Recovery of tissue integrity during menstruation ex-
hibits parallels with repair strategies documented in epi-
dermalwound healing, including inflammation, fibroblast
migration, reepithelialization, and tissue remodeling (12).
Evidence from studies of epidermal wound healing has
identified a role for androgens in this process. For example,
studies inmale ratshavereported thatblockingbiosynthesis
of DHT accelerates the reepithelialization of incisional and
excisional skin wounds (13). In mice, topical application of
the androgen receptor (AR) antagonist flutamide improves
closure of skin wounds (14). A study in men with chronic
pressure ulcers failed to show a significant benefit of treat-
mentwith theanabolic steroidoxandrolone inaphase3 trial
(15). Studies inmalemicewithglobal andselectiveablations
ofArhaveyieldedamixtureof results reflecting thedifferent
strategies used to generate knockouts [reviewed in Chang
et al. (16)]. Studies in female rodents are rare, but in one
study, topical administration of the anabolic androgen sta-
nozolol resulted in increased concentrations of type III col-
lagen and thicker scar tissue in a diabeticmousemodel (17).
These findings indicate that the role of androgens inwound
healing is context dependent and that the potential role in
females is poorly understood.
In full-thickness sections of human uterus obtained
throughout a normal menstrual cycle [see supplemental
figure in Marshall et al. (18)], our study revealed intense
immunoexpression ofAR in stromal fibroblasts in the basal
(unshed) region of the endometrium at the time of menses,
indicating that they could be a key target for androgen ac-
tion (18). Using primary human endometrial stromal cells,
we have also identified androgen-regulated genes, some of
which have been implicated in cell survival, and demon-
strated that DHT can delaywound healing in a cell-scratch
assay (18). In women with polycystic ovarian syndrome,
the ovaries typically produce excess androgens, and some
womenwith polycystic ovarian syndrome report heavy or
extended bleeding duringmenses that would be consistent
with an association between unusually high levels of cir-
culating androgens and aberrant endometrial repair (19).
The collected evidence led us to hypothesize that an-
drogens, which are maintained in the blood during
menses at a time in the cycle when estrogens and P4 are
low, may influence the dynamic changes in cell func-
tion that regulate the restoration of endometrial tissue
integrity before the onset of the proliferative phase of
the normal cycle.
In the current study, we used a mouse model of simu-
lated menses to investigate the impact of androgens on the
resolution of a naturally occurring endometrial wound.
With thismodel,wehave identifieda tightly regulated time
frame of endometrial breakdown and repair (7) and
changes in expression patterns of genes that are associated
with cellular identity, remodeling, and cellular adhesion. In
the present study,we describe novel results obtained using
this mouse model of menses and speculate that androgens
influence both the onset of menses (tissue breakdown) and
the time taken to complete scarless repair in women. We
believe that these results provide a platform for future
studies for exploring ligands that target the AR as novel
therapeutics for treatment of disorders associated with
disturbances in endometrial repair.
MATERIALS AND METHODS
Mouse model of menstruation and repair
We have described the full protocol for our mouse model of
menstruation in a prior publication (7). All mice were ovariec-
tomized to remove endogenous ovarian steroids. In the current
study, uterine tissueswere recovered only from the uterine horn,
inwhicha robustdecidualizationresponsehadbeen induced.On
d 19 of the protocol, the mice were split into 3 groups: group 1
(0 h; n = 11) had the P4 pellet in situ at the time of tissue recovery;
group 2 (untreated; n = 39) had the P4pellet removed to simulate
P4 withdrawal; group 3 [androgen (DHT) treated; n = 31] re-
ceived a subcutaneous injection of DHT (200 mg/100 ml in oil)
simultaneously with P4 pellet removal. Mice in groups 2 and 3
were culled 8, 24, 36, and 48 h after P4 withdrawal. Vaginal
smears were taken at each time point to record the presence or
absence of blood and therefore evidence of the onset, duration,
and cessation ofmenses.Uteri in all 3 groupswere dissected and
collected into eitherRNAlater (Qiagen,Hilden,Germany), or 4%
neutral-buffered formalin.
Histology and immunohistochemistry
Samples were processed and subjected to single-color immuno-
cytochemistry according to standard protocols with citrate anti-
gen retrieval (7, 20). The antibodies used were anti-cytokeratin
(C2562,mousemonoclonal; 1:100; Sigma-Aldrich, Paisley, United
Kingdom), anti-AR (SP107, rabbit monoclonal; 1:100; Spring Bio-
sciences, Pleasanton, CA, USA), anti-matrix metalloproteinase
(MMP) 3 (ab52915, rabbitmonoclonal; 1:500; Abcam, Cambridge,
United Kingdom), anti-MMP9 (sc-10737, rabbit polyclonal; 1:750;
Santa Cruz Biotechnology, Dallas, TX, USA), and anti-caspase 3
(9661, rabbitpolyclonal1:400;CellSignalingTechnology,Danvers,
MA, USA). Appropriate ImmPRESS horseradish peroxidase
Polymer Detection Kits (Vector Laboratories, Burlingame, CA,
USA) were used [anti-mouse Ig (rat absorbed) and anti-rabbit
Ig], and signals were detected by incubation with 3,39-dia-
minobenzidine horseradish peroxidase substrate (Vector Labo-
ratories) and counterstained with hematoxylin and eosin.
RNA extraction
Uterine samples were added to RNeasy Lysis Buffer with 1%
2-mercaptoethanol and homogenized. Lysates were added to
RNeasy spin columns,and totalRNAwaselutedaccording to the
manufacturer’s instructions (Qiagen).
Array analysis with the RT2 profiler PCR array
RNA was analyzed with an RNA 6000 Nano kit (Agilent
Technologies, Stockport, United Kingdom), according to the
manufacturer’s protocol: only samples with an RNA integrity
number.6.0 were used in the array. RNA samples (400 ng/ml)
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were treated to eliminate genomic DNA before preparation of
cDNA and analysis using the RT2 profilerMouse Epithelial-to-
MesenchymalTransitionArray (PAMM-090Z;Qiagen,Manchester,
United Kingdom) with buffers supplied by the manufacturer;
the full list of genes detected by the SYBRGreen-optimized primer
assays can be found online (http://www.sabiosciences.com/rt_pcr_
product/HTML/PAMM-090Z.html). Analysis was performed as
has been described (7), and mRNA concentrations in uterine
homogenates prepared fromgroup 2 and 3mice recovered 24 h
after P4 withdrawal were compared to those in group 1. Stu-
dent’s t tests determined significance.
Quantitative RT-PCR
Reverse transcription of RNA to cDNAwas performed with the
Superscript VILO cDNA synthesis kit (Thermo Fisher Scientific
Life Sciences,Loughborough,UnitedKingdom), according to the
manufacturer’s instructions. RNA samples (100 ng/ml) were in-
cubated at 25°C for 10min, 42°C for 60min, and 85°C for 5min in
a thermal cycler. Primers for each gene of interest were designed
by the Universal Probe Library Assay Design Center (Roche
Applied Science, Penzberg, Germany) and purchased from
Eurofins MWG Operon (Ebersberg, Gemany). (Sequences are
shown in Supplemental Table 1.) Reactions were prepared in
duplicate. Amplificationwas performed at 95°C for 10min and
then 40 cycles of 95°C for 15 s and 60°C for 1min. Analysis was
performed by using the DDCtmethod, where each sample was
expressed relative to the endogenous control 18s. For all PCR
analyses, all samples were compared to the 0 h sample set
(group 1), according to the array, and values were plotted as
fold changes 6 SEM.
Chromatin immunoprecipitation
Putativeandrogenresponseelements (AREs)within500bpof the
transcriptionstart siteofgenesof interestwere identifiedbyusing
theMapperdatabase (21).With theseputative sites as aguide,we
designed 2 sets of primers for each gene using ENSEMBL (www.
ensembl.org/index.html) andPrimer3 (http://primer3.ut.ee/). Primers
were purchased from Eurofins MWG Operon. (See Supplemen-
tal Table 1 for sequences.)
Chromatin extraction was performed using the truChIP Chro-
matin Shearing Kit (Covaris, Woburn, MA, USA), per the manu-
facturer’s instructions. Uteri from 4 untreated wild-type C57Bl/6J
mice were pooled so that the optimal tissue size of 80mg could be
used. Samples were sonicated at 4°C on a Bioruptor (Diagenode,
Seraing, Belgium) to shear the chromatin to 200–1000 bp. Sheared
supernatants were carried forward to chromatin immunoprecipi-
tation (ChIP), which was performed with the MAGnify Chroma-
tin Immunoprecipitation System (Thermo Fisher Scientific Life
Sciences), according to the manufacturer’s instructions. In brief,
a ChIP-grade AR antibody (ab74272; Abcam) was coupled to
Dynabeads at 5 mg/ml for 1 h, and positive (RNA pol II) and
negative antibody controls (39097; Active Motif, Carlsbad, CA,
USA)were included at 2 and 1mg/ml, respectively. Input controls
for each samplewere included. Chromatinwas bound to the beads
at 4°C for 24 h before theywerewashed. Reverse cross-linkingwas
performedat55°Cfor15min,and theDNAwaspurified,washed,
and eluted. Extraction ofDNA for all sampleswas confirmed by
PCR analysis with a known endogenous control primer set, EF1
(53011).
PCR analysis for genes of interest was performed with stan-
dard PCR techniques, where amplification was continued for 40
cycles at 94°C for 20 s, 59°C for 30 s, and 72°C for 30 s. For every
gene of interest, an input control, positive control, and negative
control samplewere included.PCRproductswere analyzedwith
Qiaxcel (Qiagen).
RESULTS
Treatment with DHT alters the onset and
duration of vaginal bleeding
Inagreementwith results fromwomen (18) stromal cells in
the uterus of intact and ovariectomized mice express AR
with intense immunopositive staining in the nuclei of
stromal fibroblasts (22). Thus, the impact of DHT was
investigated.
In untreated (group 2) female mice (Fig. 1A), vaginal
bleeding (a surrogate for tissue breakdown/shedding)
wasdetectedwithin4hofP4withdrawal in5of 13animals
(;40%,), andovert bleedinghad stopped in allmiceby the
24-h timepoint. In contrast, group3,DHT-treated females,
had a slower onset and longer duration of bleeding. Al-
though only 1 androgen-treated mouse (17%) had blood
cells in the vagina at the 4-h timepoint, the proportion had
risen to 100% (n = 10) at the 24-h time point, and this was
also the case in 3 of 5 animals at 36 h. No blood was de-
tected at 48 h, suggesting that endometrial healing was
complete. Injection of DHT also had a significant impact
on the uterine wet weight of the decidualized horn at the
24- and 36-h time points when compared with tissues re-
covered from group 2 animals, consistent with a delay in
endometrial shedding and breakdown (Fig. 1B).
Histologic evaluation revealed that androgen
supplementation had an impact on both the
onset of breakdown and the restoration of
epithelial integrity
Endometrial tissue collected fromgroup1 females (Fig. 2A,
B, 0 h) exhibited a robust decidualization response char-
acterized by the presence of large nuclei in the stromal cell
mass (inset, higher magnification). In line with expecta-
tions, 8 h after removal of the P4 pellets from group 2mice
(Fig. 2E, F), the decidualized tissue mass had detached
from the underlying basal layer, leaving the stromal com-
partment exposed and without an overlying epithelium
(no layer of cytokeratin-positive epithelial cells; brown
stain). In contrast, in group 3 (DHT-treated) females, the
decidual mass had not detached from the basal layer,
and there was an intact cytokeratin-positive epithelium
lining the lumen (Fig. 2G,H). However, in these females,
there were detectable erythrocytes in the decidual cell
mass, which was consistent with the initiation of break-
downand coincidedwith detection of blood in the vagina
at that time.
At the 24-h time point, a striking difference between
uterine tissue architecture in group 2 and 3 females was
detected. In group 2 females (Fig. 2I, J), the decidual cell
masswas detached from the underlying stroma, but some
cytokeratin-positive cells were detected adjacent to the
lumen (Fig. 2J). In the group 3 animals (Fig. 2K, L), the
decidualized mass had broken down, but detachment
from the basal compartment was incomplete (Fig. 2K),
consistentwith a delay in breakdown and shedding. Cells
immunopositive for pan cytokeratin were also detected in
the basal layer of the tissue, but were restricted to small
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areas (Fig. 2L). No residual luminal epithelium was pre-
sent, which, based on our previous findings (7), may have
contributed to a delay in repair.
At the 36-h time point, the luminal epithelium in
group 2 animals (Fig. 2M, N) was intact, denoted by a
continuous layer of cytokeratin-positive epithelial cells,
consistent with completion of epithelial repair. In con-
trast, in group 3 animals (Fig. 2O, P), remnants of the
functional decidua failed to detach from the underlying
stroma and the luminal compartment did not fully re-
epithelialize (Fig. 2P). By 48 h, an intact luminal epithe-
lium was identified in all group 2 females, with some
decidual debris remaining in the lumen (Fig. 2Q, R). An
intact cytokeratin-positive luminal epithelium was also
present in group 3 females (Fig. 2S, T); however, it was
not uniform, and the underlying stroma appeared still to
be undergoing some remodeling (Fig. 2T).
Array analysis identified androgen-
dependent changes in mRNA concentrations
of genes associated with cellular adhesion
and remodeling
In earlier work, we identified dynamic changes in con-
centrations of mRNAs encoded by key genes associated
with the process of mesenchymal–epithelial transition
during the active period of shedding and repair in our
mousemensesmodel (7). In thecurrent study,uteriofmice
from groups 2 and 3 recovered at the 24-h time pointwere
analyzedwith a PCR array to complement and extend the
data on bleeding status, uterine wet weight, and mor-
phology. Treatment with DHT generally reduced the
concentrations of mRNAs detected by the array (Sup-
plemental Table 2). Five genes—Mmp3, Mmp9, Snai3,
Ocln, and Spp1—thatwere up-regulated by greater than
10-fold in uterine samples recovered from group 2mice
relative to those in group 1 were chosen for further in-
vestigation, because in each case the array data sug-
gested a striking reduction in the concentrations of their
mRNAs in the uteri of mice in group 3 (Table 1). Vali-
dation by qRT-PCR with additional samples and new
sets of primers (Fig. 3) demonstrated a significant dif-
ference in mRNA concentrations for Mmp3, Mmp9,
Snai3, and Spp1 in DHT-treated animals at the 24-h time
point. The difference in the concentration of Ocln
mRNA was not statistically significant. Additional
analysis across all of the time points highlighted tem-
poral regulation in both groups 2 and 3 (Supplemental
Fig. 1) and revealed that, although uterine wet weights
and morphology were similar in both groups at the 48-h
time point (Figs. 1B and 2Q, T), mRNA concentrations
remained significantly different for Mmp9, Spp1, and
Ocln (P , 0.05, n = 5/group), consistent with extensive
remodeling in the DHT-treated tissue (Supplemental
Fig. 1).
Presence of a putative ARE in genes identified
by array analysis was consistent with direct
regulation of gene expression by ligand-
bound AR
The selected genes identified as androgen regulated
by the epithelial–mesenchymal transition array were
further investigated for the presence of an ARE
Figure 1. Treatment with DHT has a striking impact on onset and duration of vaginal bleeding. Bleeding observations and
uterine horn weights were recorded. A) The percentage of mice with blood in the vagina between 0 and 48 h after the withdrawal
of P4 was calculated as a percentage of mice that were identiﬁed to be bleeding at each time point of the total number of mice
examined at each time point. Note that some data from the group 2 females (black line, 0–24 h) are the same as those shown in
an earlier study (7) but the data for 36 and 48 h are new. Group 3, DHT-treated mice are indicated by the blue line. The number
of animals in each group is given in the appropriate colors below the time points. B) Upon dissection, uterine horns were cleaned
and stripped of fat and each horn weight recorded. Weights are displayed as mean grams6 SEM. Student’s t test was performed to
determine any signiﬁcance between the untreated and treated animals for each time point. Signiﬁcance was accepted as P ,
0.05.
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upstream of their promoter using the MAPPER da-
tabase (21). Putative AREs were then analyzed by
ChIP of tissue prepared from uterine horns of intact
cycling mice and an antibody specific for AR. Of the 5
genes investigated, 3—Mmp3, Snai3, and Spp1—were
identified by MAPPER as having putative AREs,
which were subsequently confirmed by ChIP (Table 2
and Supplemental Fig. 2).
Figure 2. Uterine morphology during breakdown and repair is altered with DHT treatment. Immunohistochemistry for pan-
cytokeratin (brown) highlights epithelial cell dynamics across menses. A, B) At the time of P4 withdrawal, glandular epithelial cells
in the basal layer were positive for cytokeratin. C, D) Negative primary antibody controls (NPC). E–H) At 8 h, the functional stroma
has detached from the underlying basal layer in untreated animals but not treated animals. Evidence of red blood cells is denoted
by an asterisk (H). I–L) New epithelial cells lined the luminal surface in untreated animals at 24 h ( J, open arrowheads), whereas,
in DHT-treated animals, cytokeratin-positive cells were located in the stroma (L, solid arrowheads). M, N) At the 36-h time point,
the luminal epithelium in untreated animals was intact. O, P) In DHT-treated animals, remnants of the functional decidua had
failed to detach from the underlying stroma, and the luminal compartment (P) had not fully reepithelialized. Q, R) Untreated
animals were repaired by the 48-h time point. S, T) DHT-treated animals were still undergoing remodeling at the 48-h time point
(asterisk denotes stromal remodeling) (n = 3 animals per time point). Dashed boxes enclose sections shown at higher magniﬁcation
in the following images. DCs, decidual cells; SC, shed cells; BL, basal layer; Myo, myometrium. Scale bars, 200 mm.
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Androgen treatment resulted in altered
immunoexpression of MMP9 and -P3, as well
as the apoptosis marker cleaved caspase 3
In women, MMPs are known to play a critical role in
endometrial breakdown and repair during menses,
controlling the shedding of the functional layer and
remodeling of the tissue (23–25). In this study of a
mouse model of simulated endometrial breakdown
and repair, injection of DHT resulted in significant
changes in concentrations of mRNAs encoded by
Mmp3 and Mmp9 in uterine homogenates (Fig. 3).
However, because expression of MMP proteins can
occur via transcriptional, posttranscriptional, or post-
translational mechanisms immunolocalization forMMP3
and -9 was undertaken.
Immunostaining for MMP9 revealed both temporal
and spatial expression, with staining less intense at the
24-h timepoint than at 48 h in both groups 2 and 3 (Fig. 4A
vs. Fig. 4C and Fig. 4B vs. Fig. 4D). At the 48-h time point,
intense immunoexpression of MMP9 was detected in the
luminal epitheliumandadjacent stromal cells, aswell as in
the glandular epithelium in both groups (Fig. 4C, D).
At the 24-h time point in the uteri of group 2 females,
intense immunostaining for MMP3 was localized to
areas of exposed basal stroma, consistent with active
breakdown and remodeling of the tissue (Fig. 4E), with
weak or no staining in areas where the epithelium was
intact (Fig. 4E, inset). In group 3 mice recovered at the
same time point, the decidualized functional layer had
not shed, and immunopositive staining for MMP3 was
detected throughout the decidualized mass (Fig. 4F),
but was only as intense as in group 2 mice in the basal
functional zone adjacent to the region where tissue
shedding was initiated (Fig. 4F, inset). In both groups
2 and 3, in uterine tissue recovered 48 h after P4 with-
drawal, intense immunopositive staining for MMP3
was detected in epithelial cells of the newly restored
luminal epithelium, with some residual staining in the
underlying stromal compartment in the group 3 sam-
ples (Fig. 4G, H, insets).
Immunostaining for cleaved caspase 3 revealed a striking
parallel with the pattern of expression of MMP3 at 24 h
(Fig. 4I, J vs. Fig. 4E, F), suggesting apoptosis in asso-
ciation with tissue remodeling at this time point.
Notably, caspase 3 staining was localized to areas of
exposed basal stroma in group 2 and at regions of tissue
shedding in group 3. By the 48-h timepoint, in both groups
2 and 3 (Fig. 4K, L, respectively), caspase immunostaining
TABLE 1. Summary of genes identiﬁed using the RT2 array chosen for
validation
Gene
Fold regulation
24-h untreated 24-h–DHT treated
Mmp3 61.2906 9.8823
Mmp9 28.7339 6.8393
Snai3 15.8243 0.0
Spp1 23.2021 13.5539
Ocln 11.2243 2.5191
Values are normalized to group 1, 0-h time point.
Figure 3. Genes associated with tissue remodeling, cell adhesion, and cell matrix are altered by DHT treatment. Validation of
androgen-regulated genes using samples recovered at 24 h, with or without DHT (n = 6). All samples were normalized against the
endogenous control 18s and then compared against group 1, per the PCR array. Signiﬁcance was set at P , 0.05.
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was limited to just a few cells in the luminal epithe-
lium; the underlying stromawas immunonegative. On
the basis of this evidence, it appears that the delay in
tissue breakdown and remodeling that was observed
in group 3 females was paralleled by the timing of ac-
tive cell death, as indicated by immunopositive staining
for caspase 3.
DISCUSSION
The endometrium is a remarkable tissue that may ex-
perience up to 400 episodes of breakdown and repair
over the course of a woman’s reproductive lifespan.
What ismore remarkable is its ability to repair, without
scarring, over just a few days. The endometrium is one
of only a few adult tissues that heal without formation
of a scar. Studies on wound healing in other tissue sites
have reported that oral mucosal wounds display sig-
nificantly less clinical and histologic scar formation
than corresponding skinwounds (26). Scarless repair is
also a feature of fetal tissues, and research has been
directed at understanding why fetal skin does not scar,
in the hope that such studies might help develop a
novel strategy to improve treatment for patients at risk
of excessive scar formation (27), and a greater under-
standing of the regulation of endometrial repair might
also help inform this goal.
TABLE 2. Presence of putative AR binding sites within gene promoters
Gene Putative AREa ARE conﬁrmed by ChIP
Mmp3 1 Yes
Mmp9 0 N/A
Snai3 1 Yes
Spp1 1 Yes
Ocln 0 N/A
N/A, not applicable. aWithin 500 bp of the promoter.
Figure 4. Temporal and spatial immunolocalization of MMP9, MMP3, and Caspase 3 was observed during repair and remodeling.
Cross sections of uteri from groups 2 (A, C, E, G, I, K) and 3 (B, D, F, H, J, L) recovered 24 or 48 h after P4 withdrawal are shown. A–D)
Immunostaining for MMP9 was of low intensity and largely conﬁned to stromal cells after 24 h (A, B), but with a striking increase in
both intensity and pattern at 48 h, with strong staining of epithelial cells that lined the newly restored luminal and glandular
compartments (C, D). E) In group 2 mice, at 24 h, MMP3 was localized to regions of the basal stroma that were still undergoing
reepithelialization (inset). F) In contrast, in group 3 mice, MMP3 protein was most abundant in the stromal cells at the junction of the
shedding functional layer (inset). G, H). At the 48-h time point, in both groups 2 (G) and 3 (H), MMP3 was immunolocalized to the
luminal epithelium. I–L) Spatial and temporal immunoexpression of caspase 3 largely paralleled that of MMP3 with differential
expression between group 2 (I) and 3 ( J ) samples at 24 h and most prominent staining in the epithelial compartment at 48 h (K, L)
NPC; negative primary control. LE; luminal epithelium, SC; shed cells. Scale bars, 200 mm; insets, 50 mm.
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Imaging of human endometrium during menstruation
has revealed that endometrial shedding and restoration of
an intact luminal epithelium occurs simultaneously, and
this process is thought to ensure rapid recovery of tissue
homeostasis and limit blood and fluid loss (4). Effective
endometrial repair relies on coordinated, and tightly
regulated, breakdown and tissue remodeling, to ensure
restoration of tissue integrity. Dysregulation of repair
mechanisms is thought to underlie the development
of several conditions, including oral cavity fibrosis,
Asherman’s syndrome (intrauterine fibrosis) and heavy
menstrual bleeding. Although the etiology of oral cavity
fibrosis is unclear, changes in the extracellular matrix are
thought to be caused by increased collagen production
and inflammation (28, 29). Asherman’s syndrome is an
acquiredconditioncausedbydamage to theendometrium
that has typically been associated with endometrial cu-
rettageorpelvic surgery (30,31), butmayalsooccur in20%
of women after miscarriage (32). Recent studies have re-
ported increased expression of fibrotic markers, including
collagens I and III, in endometrial tissue adhesions (33).
Novel therapeutic approaches to treat the disorder, which
have been modeled in rodents, but not yet applied in pa-
tients, include transplantation of bone marrow–derived
stem cells (34) and oral mucosal cell sheets (35).
We, and others, have used mice with induced menstru-
ation (7–9) or xenografting of human tissue fragments into
immunocompromisedmice (10) to interrogate theprocesses
that contribute to repair at the time of themenses.We have
focusedour investigationswithin a 48h repairwindow.We
have recently shown, in an ovariectomized mouse model,
that treatment with DHT can regulate uterine function,
but does not alter estrogen receptor-a expression in the
endometrium (22), supporting the data in the current
study that androgens can act independent of estrogens.
Androgenic regulation of endometrial repair has not
been considered, although it is notable that women have
significant concentrations of circulating androgens in their
bloodstream during the menstrual phase of the cycle
(1, 36). Androgens have been implicated, however, in the
regulation of endometrial receptivity and establishment
of pregnancy with evidence from in vitro studies that
decidualizing endometrial stromal cells acquire the ability
to synthesize and secrete bothT andDHT (37). Exogenous
addition of androgens to human decidualized stromal
cells appeared to protect the cells from oxidative stress
(38), suggesting that local increases in bioavailable an-
drogens within the tissue that are not detected by mea-
suring circulating concentrations of steroids also play a
role in protecting the tissue at the onset of menses in
women. Although the enzymes necessary for intrauterine
biosynthesis of androgens are also present in the mouse
uterus (39, 40), mice do not synthesize adrenal androgens
that form the key precursor pool in women. Thus, in the
current study, we used an exogenous dose of DHT to ex-
plorewhether anARagonist that cannotbemetabolized to
estrogens could have an impact on endometrial tissue
breakdown in a well-defined model. In their 1996 paper,
Zhang and Croy (41) explored the relative impacts of an-
drogens (T, DHT) and P4 onmaintenance of an artificially
induced decidualization response in mice. They showed
that multiple injections of androgens (1 or 2 mg/mouse)
maintain uterinewetweights in the absence of P4 for up to
4d, but theydidnot examine tissue afterwithdrawalof P4,
T, or DHT. In the current study, we used a 5-fold lower
dose ofDHTbut also observedmaintenanceof uterinewet
weight after a single dose ofDHT, consistentwith delayed
tissue breakdown.
Cutaneous wound healing shares several features with
endometrial wound repair at the time of menses, including
infiltration of immune cells, tissue remodeling, and reepi-
thelialization (42, 43). Studies in aging men and women
have revealed differences in the rates of cutaneous wound
healing consistentwitha role for sexhormones in regulating
these processes. Furthermore, AR has been detected in
multiple cell types in skin, including keratinocytes, dermal
fibroblasts, and macrophages. Studies in male mice (high
endogenous androgens) with selective ablation of Ar sug-
gest that keratinocyte AR promotes reepithelialization,
whereas fibroblast AR suppresses it (44). Mice that have an
inactivating mutation in their Ar gene (Tfm; testicular fem-
inization) have decreased collagen content in the skin (45).
A recent study of human endometrial stromal cells re-
ported that activation of AR is associated with changes in
genes that are involved in regulation of the cytoskeleton
(46). In our own studies, treatment of primary human
endometrial stromal cells with DHT reduced the rate of
cell migration, as determined with an in vitro wound-
healing (scratch) assay (18). Results in the current study
would also be consistent with DHT acting via AR in stro-
mal cells and thus having an impact on the rate of wound
repair. The speculation that androgens, either from the
circulation or synthesized in endometrial tissue in associ-
ation with decidualization, modulate repair of the men-
strual appear to fit with findings in males where blocking
biosynthesis of DHT using a 5a reductase inhibitor accel-
erateswound closure (47).
MMPs are well established as playing a critical role in
endometrial breakdown and repair (23, 48), and it is no-
table that bothMMP3 and -9 were differentially regulated
by androgen treatment in our model. MMP3 and -9 have
been identifiedaskeyenzymes involved inwoundhealing
and tissue repair in the skin (49), and androgens have been
reported to alter the expression of matrix proteins during
cutaneous wound healing (50). Castration of male rats
resulted in decreased expression of collagenases MMP1
and -13 and gelatinases MMP2 and -9, with greater colla-
gen deposition at wound sites. Conversely, in the current
study, treatment with androgens resulted in decreased
concentrations of MMP9, suggesting gender or tissue-
specific differences in regulation by androgens. Steroidal
regulation of MMPs is not a new concept; P4-driven in-
hibition of MMP9 was documented over 20 yr ago (51).
However, more recent studies in the baboon have dem-
onstrated that, whereas MMP7 is negatively regulated by
P4, MMP3 is regulated by a different mechanism (52). In
the current study,Mmp3was identified to contain an ARE
in its proximal promoter region and is therefore a good
candidate for being a direct target for AR-dependent gene
regulation. In contrast, no ARE was identified within
1000 bp upstream of the promoter ofMmp9, even though
we documented a robust and significant reduction in
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concentrations of its mRNA in total tissue homogenates
of the uterus ofmice treatedwithDHT.MMP3 is a known
activator ofMMP9 (53, 54), and it is thereforepossible that
DHT indirectly regulates MMP9 through MMP3 and its
cleavage of proMMP9. In this study, there were also par-
allels between the temporal–spatial immunoexpression of
MMP3 and caspase 3, providing a linkbetween androgen-
dependent gene expression and apoptosis.
The data generated by the current mouse model sug-
gest that androgens in the blood bathing the human en-
dometrium during menses could modulate the rate and
extent of breakdown of the endometrium through both
direct and indirect regulation of MMPs (and cell adhesion
molecules) to control tissue destruction and avoid excess
shedding. Based on our own studies (18), we believe an-
drogens may also reduce apoptosis of basal endometrial
fibroblasts so that they can contribute to restoration of
endometrial tissue integrity by providing both the platform
for epithelial migration and by undergoing mesenchymal–
epithelial transition (7, 55).
The recent development of nonsteroidal selective AR
modulators offers an attractive therapeutic alternative to
treatment of women with bioactive androgens, such as
DHT,which can have unwanted virilizing side effects (56).
Selective AR modulators have already passed the neces-
sarychecks forhumantrials,havebeen tested inwomenfor
muscle loss associated with cancer (57), and have been
shown to improvebonedensity and reduceosteoporosis in
both men and women (58).
CONCLUSIONS
This study of a mouse model of menses explored the role
of androgens in scarless repair of the endometrium and
provides the first evidence that AR-dependent regulation
of MMPs may contribute to regulation of wound healing
in this tissue, demonstrating parallels with cutaneous
wound healing.
The study is the first to consider a role for androgens
and theARduringmenstruation inmodulating thepaceof
endometrial shedding and repair, and we speculate that
the results obtained suggest that drugs targeting the AR
may be used for the development of treatments for endo-
metrial disorders that affect many millions of women.
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